The alternative complement pathway is associated with an adverse lipid profile: the CODAM study

被引：0

作者：

Jin, S. ^{[1
]}

Xin, Y. ^{[1
]}

van der Kallen, C. ^{[1
]}

Vogelzangs, N. ^{[1
]}

Arts, I. ^{[1
]}

Schalkwijk, C. ^{[1
]}

Stehouwer, C. ^{[1
]}

van Greevenbroek, M. ^{[1
]}

机构：

[1] Maastricht Univ, Maastricht, Netherlands

来源：

DIABETOLOGIA | 2019年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

611

引用

页码：S294 / S294

页数：1

共 50 条

[1] THE ALTERNATIVE COMPLEMENT PATHWAY IS ASSOCIATED WITH AN ADVERSE LIPID PROFILE: THE CODAM STUDY
Xin, Y.
van der Kallen, C. J. H.
Schalkwijk, C. G.
Stehouwer, C. D. A.
van Greevenbroek, M. M. J.
ATHEROSCLEROSIS, 2019, 287 : E30 - E31
[2] The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes The CODAM study
Hertle, Elisabeth
Arts, Ilja C. W.
van der Kallen, Carla J. H.
Feskens, Edith J. M.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 446 - 457
[3] The alternative pathway of complement activation is longitudinally associated with obesity: the CODAM study
Xin, Y.
Hertle, E.
van der Kallen, C.
Schalkwijk, C.
Stehouwer, C.
van Greevenbroek, M.
DIABETOLOGIA, 2016, 59 : S293 - S294
[4] C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study
Xin, Ying
Hertle, Elisabeth
van der Kallen, Carla J. H.
Vogelzangs, Nicole
Arts, Ilja C. W.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (02) : 311 - 319
[5] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
Hertle, Elisabeth
Arts, Ilja C. W.
van der Kallen, Carla J. H.
Feskens, Edith J. M.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 228 - 228
[6] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
Hertle, E.
Arts, I. C. W.
van der Kallen, C. J. H.
Feskens, E. J. M.
Schalkwijk, C. G.
Stehouwer, C. D. A.
van Greevenbroek, M. M. J.
DIABETOLOGIA, 2014, 57 : S502 - S502
[7] Associations of the alternative pathway and classical pathway of complement activation with incident metabolic syndrome: The CODAM study
Xin, Ying
Hertle, Elisabeth
van der Kallen, Carla J. H.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
MOLECULAR IMMUNOLOGY, 2017, 89 : 190 - 190
[8] Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with beta cell conservation in type 2 diabetes: the CODAM study
van Greevenbroek, M. M. J.
Xin, Y.
Schuitemaker, T.
van derKallen, C. J. H.
Hertle, E.
Schalkwijk, C. G.
Stehouwer, C. D. A.
DIABETOLOGIA, 2016, 59 : S73 - S74
[9] Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with late β-cell conservation in type 2 diabetes: The CODAM study
van Greevenbroek, Marleen
Xin, Ying
Schuitemaker, Thomas
van der Kallen, Carla
Hertle, Elisabeth
Schalkwijk, Casper
Stehouwer, Coen
MOLECULAR IMMUNOLOGY, 2017, 89 : 189 - 189
[10] Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study
Xin, Ying
Hertle, Elisabeth
van der Kallen, Carla J. H.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
OBESITY RESEARCH & CLINICAL PRACTICE, 2018, 12 (03) : 286 - 292

← 1 2 3 4 5 →